Prior to the report by Miller Her vision began to deteriorate at the age of 37 yr affecting first the left and then the right eye. She noticed that parts of her central visual field were missing. Reading became difficult at 39, she started to use a hand lens at 42 and she read her last book at 45. At 48 she could not read or write and her visual field she likened to a jigsaw puzzle which had not been put together properly. On formal examination her best visual acuity at 39 was 6/9 right eye, 6/12 left eye, at 44 it had fallen to 6/12 right eye, 6/18 left eye; and at 48 was less than 1/60 bilaterally. She had been, like her mother, night blind all her life. Her visual fields were generally constricted with absolute central scotomata, the optic discs were pale, there was marked attenuation of the retinal vessels with loss of the nerve fibre layer and of the macular pigment epithelium and overlying retina. ( The 39-year-old patient reported by King3 had developed a progressive tendency to myoclonic epilepsy and mental deterioration from the age of 17. An acute confusional state leading to coma in a 46-year-old woman with type 1 (adult) Gaucher's disease was shown at necropsy to be associated with evidence of fat embolism possibly derived from bone marrow infiltrated with Gaucher cells4 leading to diffuse intravascular coagulation. Other authors have suggested an association with the development of a peripheral cryoglobulinaemic neuropathy5 and a familial psychosis.6 There are earlier reports in the literature of patients with a clinical diagnosis of Gaucher's disease before the availability of specific enzyme assays who have developed neurological involvement after the first decade of life.78 In the case described by Davidson,8 a 26-year-old Polish Jew with adult Gauchers disease and facial immobility, swelling and loss of cells in the putamen and The ocular abnormalities associated with type 1 (adult) Gaucher's disease have included cuneiform, triangular thickening of the bulbar conjuntiva on the nasal and temporal sides of the corneoscleral limbus,2 retinal haemorrhages and oedema,4 a macular red spot'4 and perimacular degeneration.'5- '7 The patient described in this communication had been diagnosed as a case of type 1 (adult) Gaucher's disease on the basis of histology of the bone marrow, spleen and liver, characteristic radiological changes, a raised serum acid phosphatase (uninhibited by l-tartrate) and a reduced level of white cell glucocerebrosidase activity within the range of type 1 (adult) Gaucher's disease. Until the age of 38 her clinical course had been entirely in keeping with that diagnosis. Although minimal cystic changes at the macula have been previously described in type 1 Gaucher's disease, the extent of involvement in the present case is remarkable. Our patient had an extrapyramidal syndrome characterised by an initially dopamine responsive bradykinesia and rigidity without tremor. It is possible that idiopathic nigrostriatal degeneration has occurred coincidentally in this patient and that the combination of hereditory night blindness or some other disease and adult type 1 Gaucher's has given rise to her tapeto-retinal degeneration. However, it is perhaps equally likely that an extrapyramidal syndrome and progressive tapeto-retinal degeneration is a true late onset manifestation of type' 1 Gaucher's disease. In juvenile Gaucher's disease, for example, extrapyramidal features are frequently encountered,2 and in the cases described by Neil, Glew and Peters6 extrapyramidal features were described in two of their three cases who also had a psychosis. The biochemical factors that determine the later development of neurological involvement in type 1 (adult) Gaucher's disease require to be clarified. The present case had an early onset and low levels of enzyme activity both of which could conceivably be relevant in that respect. 
